Richard P. McCabe

764 total citations
26 papers, 606 citations indexed

About

Richard P. McCabe is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Richard P. McCabe has authored 26 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 7 papers in Immunology. Recurrent topics in Richard P. McCabe's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Peptidase Inhibition and Analysis (5 papers). Richard P. McCabe is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Peptidase Inhibition and Analysis (5 papers). Richard P. McCabe collaborates with scholars based in United States, United Kingdom and Netherlands. Richard P. McCabe's co-authors include Nicholas Pomato, Martin V. Haspel, Michael G. Hanna, Soldano Ferrone, Leona C. Peters, Abdel‐Aziz A. Elgamal, Luc Baert, Freddy Cornillie, M. G. Hanna and Herbert Hoover and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Richard P. McCabe

25 papers receiving 537 citations

Peers

Richard P. McCabe
A A Epenetos United Kingdom
Richard P. Moriarty United States
Mischa Houtkamp Netherlands
Olivier Léger United Kingdom
Shankar K. Nayak United States
Martijn Gerretsen Netherlands
Elaine J. Derbyshire United Kingdom
A Chodera United States
A A Epenetos United Kingdom
Richard P. McCabe
Citations per year, relative to Richard P. McCabe Richard P. McCabe (= 1×) peers A A Epenetos

Countries citing papers authored by Richard P. McCabe

Since Specialization
Citations

This map shows the geographic impact of Richard P. McCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. McCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. McCabe more than expected).

Fields of papers citing papers by Richard P. McCabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. McCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. McCabe. The network helps show where Richard P. McCabe may publish in the future.

Co-authorship network of co-authors of Richard P. McCabe

This figure shows the co-authorship network connecting the top 25 collaborators of Richard P. McCabe. A scholar is included among the top collaborators of Richard P. McCabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard P. McCabe. Richard P. McCabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elgamal, Abdel‐Aziz A., et al.. (1996). Free-to-Total Prostate Specific Antigen Ratio as a Single Test for Detection of Significant Stage T1c Prostate Cancer. The Journal of Urology. 156(3). 1042–1049. 79 indexed citations
2.
Hoosein, Naseema M., Mansoor Abdul, Richard P. McCabe, et al.. (1995). Clinical significance of elevation in neuroendocrine factors and interleukin-6 in metastatic prostate cancer. Urologic Oncology Seminars and Original Investigations. 1(6). 246–251. 43 indexed citations
3.
Pomato, Nicholas, et al.. (1995). Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation. Bioconjugate Chemistry. 6(4). 367–372. 8 indexed citations
4.
Erdi, Alev K., B. W. Wessels, Yusuf E. Erdi, et al.. (1994). Tumor activity confirmation and isodose curve display for patients receiving iodine-131-labeled 16.88 human monoclonal antibody. Cancer. 73(S3). 932–944. 15 indexed citations
5.
Rosenblum, M. G., et al.. (1994). Clinical pharmacology and tissue disposition studies of131I-labeled anticolorectal carcinoma human monoclonal antibody LiCO 16.88. Cancer Immunology Immunotherapy. 39(6). 397–400. 9 indexed citations
6.
Ramaswamy, S., et al.. (1992). New chelating agent for attaching indium-111 to monoclonal antibodies: in vitro and in vivo evaluation. Bioconjugate Chemistry. 3(3). 248–255. 9 indexed citations
7.
Bos, Ebo, et al.. (1991). Passive immunotherapy of cancer: perspectives and problems. Journal of Controlled Release. 16(1-2). 101–111. 10 indexed citations
8.
Steis, Ronald G., Jorge A. Carrasquillo, Richard P. McCabe, et al.. (1990). Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma.. Journal of Clinical Oncology. 8(3). 476–490. 43 indexed citations
9.
Haisma, Hidde J., et al.. (1990). Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and man.. PubMed. 10. 40–3. 8 indexed citations
10.
Suciu‐Foca, Nicole, Patricia M. McManus, Elaine F. Reed, et al.. (1989). Anti-HLA antibodies in recipients of renal allografts.. PubMed. 21(1 Pt 1). 754–5. 3 indexed citations
11.
Haspel, Martin V., Richard P. McCabe, Nicholas Pomato, et al.. (1985). Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.. PubMed. 45(8). 3951–61. 96 indexed citations
12.
Ransom, Janet H., Charles H. Evans, Richard P. McCabe, et al.. (1985). Leukoregulin, a direct-acting anticancer immunological hormone that is distinct from lymphotoxin and interferon.. PubMed. 45(2). 851–62. 54 indexed citations
13.
McCabe, Richard P., Donald L. Lamm, Martin V. Haspel, et al.. (1984). A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin(ogen) degradation products.. PubMed. 44(12 Pt 1). 5886–93. 32 indexed citations
14.
McCabe, Richard P. & Charles H. Evans. (1983). The Regulatory Role of Extracellular Proteases in Tumor Growth. Pathology and Immunopathology Research. 2(1-2). 1–9. 3 indexed citations
15.
McCabe, Richard P. & Charles H. Evans. (1982). Plasminogen activator, fibronectin, lymphotoxin sensitivity, and natural skin reactivity relationships to guinea pig cell tumorigenicity.. PubMed. 68(2). 329–36. 4 indexed citations
16.
McCabe, Richard P., et al.. (1979). A Radioimmunometric Antibody-Binding Assay for Evaluation of Xenoantisera to Melanoma-Associated Antigens23. JNCI Journal of the National Cancer Institute. 62(3). 455–463. 23 indexed citations
17.
McCabe, Richard P., Soldano Ferrone, Michele Pellegrino, et al.. (1978). Purification and Immunologic Evaluation of Human Melanoma-Associated Antigens 2 3. JNCI Journal of the National Cancer Institute. 60(4). 773–777. 24 indexed citations
18.
Sharma, Meenu, James A. Gregg, Matthew S. Loewenstein, Richard P. McCabe, & Norman Zamcheck. (1976). Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis. Cancer. 38(6). 2457–2461. 29 indexed citations
19.
McCabe, Richard P., Herbert Z. Kupchik, Calvin A. Saravis, et al.. (1976). Demonstration and Immunochemical Characterization of Carcinoembryonic Antigen in Human Pancreatic Juice 2 3. JNCI Journal of the National Cancer Institute. 56(5). 885–889. 8 indexed citations
20.
Saravis, Calvin A., et al.. (1974). Solid-Phase Radioimmunoelectrophoresis: An Assay for Carcinoembryonic Antigen2. JNCI Journal of the National Cancer Institute. 53(4). 921–926. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026